U.S. market Open. Closes in 5 hours 30 minutes

ALRN | Aileron Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue119.00K169.00K121.00K163.00K155.00KN/AN/AN/AN/A
Gross Profit-119.00K-169.00K-121.00K-163.00K-155.00KN/AN/AN/AN/A
Operating Expenses16.28M27.65M26.61M20.50M29.96M31.90M23.01MN/AN/A
Selling, General & Admin11.36M9.68M9.60M9.33M12.29M13.45M8.77MN/A5.06M
Research & Development3.99M17.97M17.01M11.17M17.66M18.45M14.24M10.28M7.83M
Other Operating Expenses928.00K318.00K441.00K-800.00KN/AN/AN/A-18.17M-12.89M
Operating Income-16.28M-27.65M-26.61M-20.50M-29.96M-31.90M-23.01M-18.17M-12.89M
Other Expenses / Income544.00K318.00K400.00K-661.00K587.00K355.00K404.00K46.00K13.00K
Before Tax Income-15.73M-27.33M-26.20M-21.16M-29.37M-31.55M-22.60M-18.12M-12.88M
Income Tax Expenses928.00K-318.00K-441.00K661.00K-587.00K355.00KN/AN/AN/A
Net Income-15.73M-27.01M-25.76M-21.82M-28.78M-31.55M-22.60M-18.12M-12.88M
Interest ExpensesN/A-318.00KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding4.60M4.54M4.44M1.74M1.23M736.91K372.15K9.50M10.91M
Diluted Shares Outstanding4.60M4.54M4.44M1.74M1.23M736.91K372.15K9.50M10.91M
EBITDA-15.23M-27.48M-26.88M-19.67M-29.80M-31.68M-22.48M-17.94M-12.57M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-14.80M-27.65M-26.20M-21.16M-29.37M-31.19M-22.60M-18.12M-12.88M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙